MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Bruker Corporation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR - Bruker today announces the release of the B.I.QUANT-UR™ 1.1 module - Bruker.com
Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR

 

NewswireToday - /newswire/ - Faellanden, Switzerland, 2020/02/17 - Bruker today announces the release of the B.I.QUANT-UR™ 1.1 module - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Important Note: the methods and solutions described in this press release are for research use only and not for use in clinical diagnostic procedures

Bruker today announces the release of the B.I.QUANT-UR™ 1.1 module, the only analysis solution on the market that complies with DIN-ISO criteria for the identification and quantification of urine metabolites on Bruker’s nuclear magnetic resonance (NMR) in-vitro diagnostic research (Avance™ IVDr) platforms. The module automatically quantifies up to 150 endogenous and disease-related metabolites from urine, allowing users to obtain precise, sensitive and fully reproducible results, even below the limit of detection (LOD).

NMR produces highly reliable quantification values from a single experiment, which would traditionally require multiple tests with different sample preparations using techniques such as conventional gas chromatography mass spectrometry (GC-MS) or ion exchange chromatography mass spectrometry (IEC-MS). B.I.QUANT-UR 1.1 combines the raw concentration of a compound with quality assessment parameters to obtain reliable quantification results, and has demonstrated great potential in clinical and translational research. The new module introduces two additional parameters to provide confidence in quantification: signal correlation (ρ, %) to characterize the match between the lineshape metabolite signal and the calculated fit, with color coded flags added for improved visualization; and concentration error (Δ, mmol/L), for the concentration equivalent of the difference between metabolite signal and the calculated fit.

A key challenge in quantifying metabolites in urine is the complexity of the sample, which contains thousands of compounds generating multiple NMR signals. A unique feature of B.I.QUANT-UR includes DIN-ISO conformant wet spiking, to identify correct signals where there is significant overlap. This upgraded version of the successful B.I.QUANT-UR 1.0 module represents another iteration of a unique feature known as numerical spiking, where pure compound spectra of all 150 metabolites are automatically added to more than 20,000 urine spectra, and subjected to the quantification algorithm to determine the respective probabilistic LOD.

Dr. Manfred Spraul, CTO of the Applied, Industrial and Clinical (AIC) Division at Bruker BioSpin, commented: “Here we have a fully validated research use only system including DIN-ISO spiking with which B.I.QUANT-UR 1.1 is fully compatible. With this module, users can go substantially below the LOD to obtain meaningful results and use the two new parameters to judge if the result can be trusted, in order to achieve substantially more quantifications than before.”

About Bruker Corporation

Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Introduces Updated B.I.QUANT-UR™ Module for Fully Validated Metabolite Quantification in Urine Using NMR

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Dr. Thorsten Thiel - Bruker.com 
+49(721) 5161 6500 thorsten.thiel[.]bruker.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

Medical Devices to Revolutionize with the Integration of Cloud, IoT and AI for Improved Patient Outcomes
NorthStar Commended by Frost & Sullivan for its RadioGenix® System, An Innovative High-Tech Separation Platform for Processing Non-Uranium-based Mo-99
Imec Begins Developing SARS-CoV-2 Test to Identify Positive Cases and Confirm Whether Someone is Contagious
Hyperfine Lauded by Frost & Sullivan for Developing the World’s Only Portable MRI System for Point of Care
CoverMyMeds Lauded by Frost & Sullivan for Seamlessly Connecting the Healthcare Network with its Industry-leading ePA Platform
SCHOTT AG and Credence MedSystems Form a Strategic Collaboration Agreement to Make Syringe Injections Safer for the Benefit of Patients Worldwide
Smartphone-based Solutions Boost Global Infectious Disease Point-of-Care Testing Market At An Explosive CAGR of 70.2% in 2020 Finds Frost & Sullivan
Artificial Intelligence, Tele-ophthalmology, and IoT to Drive the Ophthalmic Diagnostic and Monitoring Devices Market Finds Frost & Sullivan
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
KRAIBURG TPE and NEXTIS Partner on Flexible USB Socket Protection Cover Molded in THERMOLAST® for Respiratory Devices
Hyland Healthcare Receives Frost & Sullivan’s 2020 North America Product Leadership Award for Creating a New Standard in PACS Technology
VDL and DSM Form Joint Venture to Manufacture and Commercialize Medical Facemasks and PPE Filter Materials
Charge and Sanitize Mobile Devices with Tripp Lite’s New Hospital-Grade UV Charging Stations
Candelis Lauded by Frost & Sullivan for Accelerating Accurate Diagnosis with its Multi-Modal Breast Imaging Solution, Advanced Breast Imaging Enterpri
Cutting-Edge micro-CT Imaging Research Shines New Light on Mooted SARS-CoV-2 Treatments

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)